26 September - 2 October 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Effect of the pandemic on MS services
Seven in ten people with MS hadn't been able to contact a rehabilitation professional and four in ten had had appointments cancelled, according to an MS Society survey. A woman with MS describes how the lack of support has affected her.
Source: Aberdeen Press & Journal
MS Trust link: Map of MS services
MS doesn't increase Covid risk
Taking a disease modifying drug (DMD), the type of MS or disability level were not associated with a higher risk of getting Covid-19 during the lockdown period, according to data from the UK MS Register. An analysis of a smaller group who had has the infection found no clear evidence that DMD use, type of MS or how long someone had been diagnosed affected how they recovered from Covid-19
Source: MS News Today
MS Trust link: Coronavirus, Covid-19 and multiple sclerosis
Study finds Covid risk with some DMDs
The risk of a more severe outcome for people with MS compared to the general population remains low. However, those taking either rituximab or Ocrevus were more likely to have a more severe course of Covid-19 than people taking other disease modifying drugs (DMDs) according to shared data from 21 countries. Other studies have seen different results.
Source: Medpage Today
MS Trust link: MS Decisions - a guide to disease modifying drugs for relapsing remitting multiple sclerosis
Mental health and cardiovascular conditions and MS
People with MS are more likely to have other conditions (comorbidities), according to two recent studies. One study found that one in five people have a mental health or psychiatric condition, including depression, and about one in seven have cardiovascular disease, such as high blood pressure. A second study found that people with MS were more than two and half times more likely than the general population to have mental health issues, most commonly mood disorders.
MS Trust link: Comorbidity
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.